telmisartan has been researched along with Cardiomegaly in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lan, Y; Li, X; Lu, Y; Nie, M; Wang, Y; Zhao, E | 1 |
| Alter, ML; Chaykovska, L; Hocher, B; Hohmann, M; Klein, T; Kraft, R; Kutil, B; Reichetzeder, C; Tsuprykov, O; von Websky, K | 1 |
| Guo, J; Huo, CJ; Kang, YM; Li, HB; Li, X; Liu, JJ; Shi, XL; Su, Q; Yuan, ZY; Zhu, GQ | 1 |
| Hongo, K; Kawai, M; Komukai, K; Mochizuki, S; Morimoto, S; Nagai, M; Seki, S; Taniguchi, I; Yoshimura, M | 1 |
| Ge, J; Gong, H; Komuro, I; Li, L; Lin, L; Wu, J; Zhou, N; Zou, Y | 1 |
| Böhm, M; Caglayan, E; Ghanem, A; Gross, ML; Huntgeburth, M; Mödersheim, S; Müller-Ehmsen, J; Rosenkranz, S; Schlüter, KD; Schreckenberg, R; Shahverdyan, R; Tiemann, K; Vantler, M; Zimmermann, WH | 1 |
| Böhm, M; Friedrich, EB; Jagoda, P; Kazakov, A; Laufs, U; Müller, P; Semenov, A | 1 |
| Goyal, BR; Mehta, AA | 1 |
| Leenen, FH; Liang, B | 1 |
9 other study(ies) available for telmisartan and Cardiomegaly
| Article | Year |
|---|---|
Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Cardiomegaly; Cell Nucleus; Male; Mice; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Signal Transduction; Telmisartan | 2017 |
Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Blood Pressure; Cardiomegaly; Collagen Type I; Constriction, Pathologic; Cystatin C; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Fibrosis; Heart; Hypertension, Renovascular; Kidney; Linagliptin; Lipoproteins, LDL; Male; Oxidative Stress; Purines; Quinazolines; Random Allocation; Rats; Rats, Wistar; Surgical Instruments; Telmisartan | 2013 |
TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Benzimidazoles; Benzoates; Cardiomegaly; Cytokines; Hypertension; Male; Myeloid Differentiation Factor 88; NF-kappa B; Nitric Oxide Synthase Type II; Norepinephrine; Paraventricular Hypothalamic Nucleus; PPAR gamma; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Telmisartan; Toll-Like Receptor 4 | 2016 |
Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive rats.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Vessels; Cardiomegaly; Cell Size; Coronary Vessels; Fibrosis; Heart Diseases; Hemodynamics; Hypertension, Renovascular; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Wistar; Telmisartan | 2009 |
Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Echocardiography; Gene Expression; Hemodynamics; Imidazoles; Losartan; Male; Mice; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
Transforming growth factor β₁ oppositely regulates the hypertrophic and contractile response to β-adrenergic stimulation in the heart.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cardiomegaly; Cells, Cultured; Echocardiography, Stress; Gene Expression Regulation; Heart; Humans; Ion Channels; Isoproterenol; Metoprolol; Mice; Mice, Transgenic; Mitochondrial Proteins; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Transforming Growth Factor beta1; Uncoupling Protein 3 | 2011 |
Ramipril and telmisartan exhibit differential effects in cardiac pressure overload-induced hypertrophy without an additional benefit of the combination of both drugs.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Cardiomegaly; Drug Therapy, Combination; Endothelial Cells; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocardium; Ramipril; Stem Cells; Telmisartan | 2013 |
Beneficial role of spironolactone, telmisartan and their combination on isoproterenol-induced cardiac hypertrophy.
Topics: Adrenergic beta-Agonists; Algorithms; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; C-Reactive Protein; Cardiomegaly; Creatine Kinase, MB Form; Disease Models, Animal; Diuretics; Drug Therapy, Combination; Dyslipidemias; Hemodynamics; Injections, Intraperitoneal; Isoproterenol; Rats; Rats, Wistar; Spironolactone; Telmisartan; Treatment Outcome | 2012 |
Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Benzoates; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Fibrosis; Heart Rate; Hypertension; Hypertrophy; Kidney; Losartan; Male; Myocardium; Organ Specificity; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium, Dietary; Telmisartan | 2008 |